Decision Support Techniques

• 

  Subject Areas on Research

  • "If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits. 
  • 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • Four Conversations : A Randomized Controlled Trial of an Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients. 
  • A Bayesian approach for individual-level drug benefit-risk assessment. 
  • A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial. 
  • A Decision Aid to Promote Appropriate Colorectal Cancer Screening among Older Adults: A Randomized Controlled Trial. 
  • A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. 
  • A Smartphone-based Decision Support Tool Improves Test Performance Concerning Application of the Guidelines for Managing Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy. 
  • A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing? 
  • A Triage Model for Interhospital Transfers of Low Risk Intracerebral Hemorrhage Patients. 
  • A calibration hierarchy for risk models was defined: from utopia to empirical data. 
  • A clinical decision and economic analysis model of cancer pain management. 
  • A combined paging alert and web-based instrument alters clinician behavior and shortens hospital length of stay in acute pancreatitis. 
  • A cost analysis of hematopoietic colony-stimulating factors. 
  • A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. 
  • A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. 
  • A decision aid for teaching limitations of prostate cancer screening. 
  • A decision exercise to engage cancer patients and families in deliberation about Medicare coverage for advanced cancer care. 
  • A demonstration of ''less can be more'' in risk graphics. 
  • A framework to evaluate the cost-effectiveness of the NADiA ProsVue slope to guide adjuvant radiotherapy among men with high-risk characteristics following prostatectomy for prostate cancer. 
  • A model to predict limb salvage in severe combat-related open calcaneus fractures. 
  • A model to predict risk of blood transfusion after gynecologic surgery. 
  • A model to predict risk of postpartum infection after Caesarean delivery. 
  • A novel decision aid for acute myeloid leukemia: a feasibility and preliminary efficacy trial. 
  • A novel multi-relation regularization method for regression and classification in AD diagnosis. 
  • A novel scoring system for predicting postoperative venous thromboembolic complications in patients after open aortic surgery. 
  • A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy. 
  • A prospective study of modified Ottawa ankle rules in a military population. Interobserver agreement between physical therapists and orthopaedic surgeons. 
  • A quantitative measure of diabetes risk in community practice impacts clinical decisions: the PREVAIL initiative. 
  • A review of decision aids to assess cardiovascular risk. 
  • A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke. 
  • A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. 
  • A systematic process for converting text-based guidelines into a linear algorithm for electronic implementation. 
  • A team-based approach to patients in cardiogenic shock. 
  • A universal decision support system. Addressing the decision-making needs of patients, families, and clinicians in the setting of critical illness. 
  • A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. 
  • ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. 
  • Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. 
  • Advanced Imaging Adds Little Value in the Diagnosis of Femoroacetabular Impingement Syndrome. 
  • Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. 
  • Allocation of vascularized composite allografts: what is it? 
  • American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. 
  • An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department. 
  • An analytic decision support tool for resident allocation. 
  • An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. 
  • An exploration of relative health stock in advanced cancer patients. 
  • An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. 
  • An overview and discussion of the Patient-Centered Outcomes Research Institute's decision aid portfolio. 
  • Analysis of model development strategies: predicting ventral hernia recurrence. 
  • Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. 
  • Anticoagulation: managing adverse events in patients receiving anticoagulation and perioperative care. 
  • Anticoagulation: monitoring of patients receiving anticoagulation. 
  • Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. 
  • Applying the neoadjuvant paradigm to ductal carcinoma in situ. 
  • Approaches for optimal sequential decision analysis in clinical trials. 
  • Are adult patients more tolerant of treatment risks than parents of juvenile patients? 
  • Are models better than cardiologists?: An analysis of risk prediction in heart failure. 
  • Are we ready to predict late effects? A systematic review of clinically useful prediction models. 
  • Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application. 
  • Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model. 
  • Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. 
  • Auditory decision aiding in supervisory control of multiple unmanned aerial vehicles. 
  • Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? 
  • Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. 
  • Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. 
  • Breast cancer anxiety's associations with responses to a chemoprevention decision aid. 
  • Building knowledge in a complex preterm birth problem domain. 
  • CKD as a Model for Improving Chronic Disease Care through Electronic Health Records. 
  • CRISP: Catheterization RISk score for Pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC). 
  • Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction? 
  • Case-based reasoning computer algorithm that uses mammographic findings for breast biopsy decisions. 
  • Causal relationships of processes of change and decisional balance: stage-specific models for smoking. 
  • Cell-free DNA for Down syndrome screening in obese women: Is it a cost-effective strategy? 
  • Charting a path for innovative toilet technology using multicriteria decision analysis. 
  • Clinical Prediction Models for Sleep Apnea: The Importance of Medical History over Symptoms. 
  • Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease. 
  • Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review. 
  • Clinical prediction rules for physical therapy interventions: a systematic review. 
  • Cognitive errors and logistical breakdowns contributing to missed and delayed diagnoses of breast and colorectal cancers: a process analysis of closed malpractice claims. 
  • Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. 
  • Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. 
  • Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. 
  • Comparative effectiveness research: moving medical oncology forward. 
  • Comparison of an automated thrombolytic predictive instrument to both diagnostic software and an expert cardiologist for diagnosis of an ST elevation acute myocardial infarction. 
  • Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults. 
  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer. 
  • Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. 
  • Cost effectiveness analysis of hemiarthroplasty and total shoulder arthroplasty. 
  • Cost effectiveness of a test to detect metastases for endometrial cancer. 
  • Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. 
  • Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. 
  • Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. 
  • Cost-Effectiveness Analysis of Early Reconstruction Versus Rehabilitation and Delayed Reconstruction for Anterior Cruciate Ligament Tears. 
  • Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors. 
  • Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients. 
  • Cost-based decision analysis of postreduction imaging in the management of mandibular fractures. 
  • Cost-effectiveness analyses: a basic overview for dermatologists. 
  • Cost-effectiveness analysis of free vascularized fibular grafting for osteonecrosis of the femoral head. 
  • Cost-effectiveness analysis of the diagnosis of meniscus tears. 
  • Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. 
  • Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer. 
  • Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. 
  • Cost-effectiveness of automated external defibrillators on airlines. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. 
  • Cost-effectiveness of diabetes treatment sequences to inform step therapy policies. 
  • Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. 
  • Cost-effectiveness of fetal lung maturity testing in preterm labor. 
  • Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy. 
  • Cost-effectiveness of implantable cardioverter-defibrillators. 
  • Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States. 
  • Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States. 
  • Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. 
  • Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States. 
  • Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. 
  • Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. 
  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. 
  • Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. 
  • Cost-effectiveness of the implantable cardioverter defibrillator. 
  • Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. 
  • Cost-effectiveness of treatment of early stage endometrial cancer. 
  • Cost-effectiveness of ultrasound in preventing femoral venous catheter-associated pulmonary embolism. 
  • Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy. 
  • Cost-minimization analysis of robotic-assisted, laparoscopic, and abdominal sacrocolpopexy. 
  • Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. 
  • Curbing potential radiation-induced cancer risks in oncologic imaging: perspectives from the 'image gently' and 'image wisely' campaigns. 
  • Customized Probability of Vaginal Delivery With Induction of Labor and Expectant Management in Nulliparous Women at 39 Weeks of Gestation. 
  • Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. 
  • Decision Aid Interventions for Family Caregivers of Persons With Advanced Dementia in Decision-Making About Feeding Options: A Scoping Review. 
  • Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. 
  • Decision analytic modeling in spinal surgery: a methodologic overview with review of current published literature. 
  • Decision model for the acute treatment of mania. 
  • Decision models for assessing the cost effectiveness of drug-eluting stents. 
  • Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use. 
  • Deep Learning-Based Risk Model for Best Management of Closed Groin Incisions After Vascular Surgery. 
  • Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening. 
  • Derivation of a clinical decision guide in the diagnosis of cervical facet joint pain. 
  • Design and pilot evaluation of a system to develop computer-based site-specific practice guidelines from decision models. 
  • Design of a modular, extensible decision support system for arrhythmia therapy. 
  • Design of a randomized clinical trial of a colorectal cancer screening decision aid to promote appropriate screening in community-dwelling older adults. 
  • Design of the PReferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Trial. 
  • Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. 
  • Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. 
  • Development and pilot testing of a decision aid for surrogates of patients with prolonged mechanical ventilation. 
  • Development of a Quality Checklist Using Delphi Methods for Prescriptive Clinical Prediction Rules: the QUADCPR. 
  • Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. 
  • Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions. 
  • Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. 
  • Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma. 
  • Do Urinary Cystine Parameters Predict Clinical Stone Activity? 
  • Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults? Study protocol for a randomized controlled trial. 
  • Do risk calculators accurately predict surgical site occurrences? 
  • Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer? 
  • Does Ultrasonographic Measurement of Gastric Content Influence Airway Management Decisions? 
  • Does the use of a prescriptive clinical prediction rule increase the likelihood of applying inappropriate treatments? A survey using clinical vignettes. 
  • Does this patient have pulmonary embolism? 
  • Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. 
  • Early identification of uncontrolled hemorrhage after trauma: current status and future direction. 
  • Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction. 
  • Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients. 
  • Economic and radiation costs of initial imaging approaches after a child's first febrile urinary tract infection. 
  • Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention. 
  • Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. 
  • Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C. 
  • Economics of low-molecular weight heparins. 
  • Effect of Known Atrial Fibrillation and Anticoagulation Status on the Prehospital Identification of Large Vessel Occlusion. 
  • Effect of a Patient Decision Aid on Preferences for Colorectal Cancer Screening Among Older Adults: A Secondary Analysis of a Randomized Clinical Trial. 
  • Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy. 
  • Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. 
  • Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. 
  • Effectiveness of topic-specific infobuttons: a randomized controlled trial. 
  • Effects of a Personalized Web-Based Decision Aid for Surrogate Decision Makers of Patients With Prolonged Mechanical Ventilation: A Randomized Clinical Trial. 
  • Effects of a mammography decision-making intervention at 12 and 24 months. 
  • Efficacy of a Preference-Based Decision Tool on Treatment Decisions for a First-Time Anterior Shoulder Dislocation: A Randomized Controlled Trial of At-Risk Patients. 
  • Eliciting and combining subjective judgments about uncertainty. 
  • Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project. 
  • Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. 
  • Enthusiasm for prescriptive clinical prediction rules (eg, back pain and more): a quick word of caution. 
  • Errors in surgical neuropathology and the influence of cognitive biases: the psychology of intelligence analysis. 
  • Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine. 
  • Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial. 
  • Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. 
  • Estimation and validation of a multiattribute model of Alzheimer disease progression. 
  • Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward. 
  • Evaluating participants' use of a hormone replacement therapy decision-making intervention. 
  • Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. 
  • Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. 
  • Evaluation of the patient with nontraumatic headache: an evidence based approach. 
  • Exploring the potential of context-sensitive CADe in screening mammography. 
  • External Validation of a Prognostic Model for Predicting Nonresponse Following Knee Arthroplasty. 
  • Factors associated with the use of cognitive aids in operating room crises: a cross-sectional study of US hospitals and ambulatory surgical centers. 
  • Factors influencing malaria control policy-making in Kenya, Uganda and Tanzania 
  • Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial. 
  • Futility, benefit, and transcatheter aortic valve replacement. 
  • GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool. 
  • Gene expression profiling in melanoma: past results and future potential. 
  • Global judgments versus decision-model-facilitated judgments: are experts internally consistent? 
  • Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives. 
  • Guiding Clinical Decisions Through Predictive Risk Rules. 
  • Hardware Removal in Craniomaxillofacial Trauma: A Systematic Review of the Literature and Management Algorithm. 
  • Head to head randomized trial of two decision aids for prostate cancer. 
  • Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. 
  • Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial. 
  • Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. 
  • Hop tests correlate with IKDC and KOOS at minimum of 2 years after primary ACL reconstruction. 
  • How making a risk estimate can change the feel of that risk: shifting attitudes toward breast cancer risk in a general public survey. 
  • How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through. 
  • Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool. 
  • Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis? 
  • Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. 
  • Identifying Low-risk Patients for Early Discharge From Emergency Department Without Using Subjective Descriptions of Chest Pain: Insights From Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT) 3 and 4 Trials. 
  • Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. 
  • Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. 
  • Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand. 
  • Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness models. 
  • Improving evidence developed from population-level experience with targeted agents. 
  • Improving understanding of adjuvant therapy options by using simpler risk graphics. 
  • Inadvertent Arterial Placement of Central Venous Catheters: Systematic Review and Guidelines for Treatment. 
  • Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Incorporation of a Laguerre-Gauss channelized Hotelling observer for false-positive reduction in a mammographic mass CAD system. 
  • Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view. 
  • Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes. 
  • Infobuttons and classification models: a method for the automatic selection of on-line information resources to fulfill clinicians' information needs. 
  • Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention. 
  • Insurance plan presentation and decision support on HealthCare.gov and state-based web sites created for the Affordable Care Act. 
  • Integrating ethics in design through the value-sensitive design approach. 
  • Inter-observer reliability of the HERDOO2 clinical decision rule. 
  • International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions. 
  • International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. 
  • Internet Versus DVD Decision Aids for Hip and Knee Osteoarthritis. 
  • Interpreting the music of drug-eluting stents: halcyon song or albatross dirge? 
  • Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction. 
  • Intuitive theories of information: beliefs about the value of redundancy. 
  • Is Advanced Imaging to Assess Rotator Cuff Integrity Before Shoulder Arthroplasty Cost-effective? A Decision Modeling Study. 
  • Is information always a good thing? Helping patients make "good" decisions. 
  • Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. 
  • Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis. 
  • Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. 
  • Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization. 
  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. 
  • Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. 
  • MY APPROACH to the risk stratification of patients for sudden cardiac death. 
  • Machine Learning and Statistical Models to Predict Postpartum Hemorrhage. 
  • Machine-Based Expert Recommendations And Insurance Choices Among Medicare Part D Enrollees. 
  • Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. 
  • Management of atrial fibrillation. 
  • Management of atrial fibrillation. 
  • Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. 
  • Maximizing sensitivity in medical diagnosis using biased minimax probability machine. 
  • Modeling bioterrorism and disaster preparedness: SMDM's recommendations for design and reporting. 
  • Modeling choice behavior for new pharmaceutical products. 
  • Modeling recovery curves with application to prostatectomy. 
  • Monitored isoniazid prophylaxis for low-risk tuberculin reactors. 
  • Morbidity and Mortality Conference for Percutaneous Coronary Intervention. 
  • Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. 
  • My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices. 
  • Myelodysplastic syndromes. 
  • Myopic choroidal neovascularisation: current concepts and update on clinical management. 
  • Narrowing the gaps between what we know and what we do in psychiatry. 
  • Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. 
  • Nonparametric bayes testing of changes in a response distribution with an ordinal predictor. 
  • Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework. 
  • On robotic optimal path planning in polygonal regions with pseudo-Euclidean metrics. 
  • Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis. 
  • Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis. 
  • Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data. 
  • Out-of-hospital stroke screen accuracy in a state with an emergency medical services protocol for routing patients to acute stroke centers. 
  • Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. 
  • Overestimation of test effects in clinical judgment. 
  • PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease. 
  • Patient Decision Aids: A Case for Certification at the National Level in the United States. 
  • Patient and family communication during consultation visits: The effects of a decision aid for treatment decision-making for localized prostate cancer. 
  • Patient education and provider decision support to control blood pressure in primary care: a cluster randomized trial. 
  • Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. 
  • Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysis. 
  • Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. 
  • Physicians' perceptions of shared decision-making for implantable cardioverter-defibrillators: Results of a physician survey. 
  • Platelet-rich plasma vs. corticosteroid injections for the treatment of recalcitrant lateral epicondylitis: a cost-effectiveness Markov decision analysis. 
  • Population risk prediction models for incident heart failure: a systematic review. 
  • Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. 
  • Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. 
  • Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients. 
  • Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals. 
  • Predicting critical illness mortality and personalizing therapy: moving to multi-dimensional data. 
  • Predicting neonatal respiratory morbidity by lamellar body count and gestational age. 
  • Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. 
  • Predicting risk of pelvic floor disorders 12 and 20 years after delivery. 
  • Prediction Models - Development, Evaluation, and Clinical Application. 
  • Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. 
  • Prediction of insemination outcomes in Holstein dairy cattle using alternative machine learning algorithms. 
  • Predictive Model for High-Risk Coronary Artery Disease. 
  • Predictive models in heart failure: who cares? 
  • Predictors of vertigo in the emergency department: The preved study. 
  • Preoperative Renal Insufficiency: Underreporting and Association With Readmission and Major Postoperative Morbidity in an Academic Medical Center. 
  • Preoperative breast size affects reconstruction status following mastectomy. 
  • Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: a cost comparison study. 
  • Presentation and explanation of medical decision models using the World Wide Web. 
  • Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. 
  • Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. 
  • Prevention of sudden cardiac death: a probabilistic model for decision support. 
  • Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). 
  • Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. 
  • Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention. 
  • Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. 
  • Proposal of a method for deciding whether an AJR manuscript merits publication: The 25% rule. 
  • Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia. 
  • Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting. 
  • Prostate cancer screening. 
  • Publishing web-based guidelines using interactive decision models. 
  • Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. 
  • Radical prostatectomy versus radiation therapy: can pretreatment nomograms be used to select the appropriate prostate cancer treatment? 
  • Random forest for prediction of contrast-induced nephropathy following coronary angiography. 
  • Random forest modeling can predict infectious complications following trauma laparotomy. 
  • Randomized controlled trial of a scoring aid to improve Glasgow Coma Scale scoring by emergency medical services providers. 
  • Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients. 
  • Rationale for percutaneous biopsy and histologic characterisation of renal tumours. 
  • Re: Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view. 
  • Re: Uses and misuses of multicriteria decision analysis (MCDA) in environmental decision making. 
  • Reexamination of the UN10 Rule to Discontinue Resuscitation During In-Hospital Cardiac Arrest. 
  • Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. 
  • Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer. 
  • Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. 
  • Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer. 
  • Results with an algorithmic approach to hybrid repair of the aortic arch. 
  • Rethinking the objectives of decision aids: a call for conceptual clarity. 
  • Risk Adjusted Mortality Ratings and Public Reporting for High-Risk PCI. 
  • Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial. 
  • Risk Score to Predict Need for Intensive Care in Initially Hemodynamically Stable Adults With Non-ST-Segment-Elevation Myocardial Infarction. 
  • Risk assessment in atrial fibrillation: not all factors are created equal. 
  • Risk calculators are useful but.... 
  • Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies. 
  • Risk-benefit trade-offs in revascularisation choices. 
  • SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation. 
  • Screening experiments and the use of fractional factorial designs in behavioral intervention research. 
  • Screening for cervical cancer: a modeling study for the US Preventive Services Task Force. 
  • Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. 
  • Sensitivity analysis on a chance node with more than two branches. 
  • Shared Decision Making in Patients With Suspected Uncomplicated Ureterolithiasis: A Decision Aid Development Study. 
  • Shopping on the Public and Private Health Insurance Marketplaces: Consumer Decision Aids and Plan Presentation. 
  • Simplified Predictive Instrument to Rule Out Acute Coronary Syndromes in a High-Risk Population. 
  • Single-number summary and decision analytic measures can happily coexist. 
  • Statins after intracerebral hemorrhage: to treat or not to treat. 
  • Staying away from the optic nerve: a formula for modifying glaucoma drainage device surgery in pediatric and other small eyes. 
  • Stereotactic breast biopsy of noncalcified lesions: a cost-minimization analysis comparing 14-gauge multipass automated core biopsy to 14- and 11-gauge vacuum-assisted biopsy. 
  • Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time. 
  • Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. 
  • Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis. 
  • Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. 
  • Structuring clinical practice guidelines in a relational database model for decision support on the Internet. 
  • Survey of patient and physician influences and decision-making regarding CT utilization for minor head injury. 
  • Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool. 
  • TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. 
  • Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis. 
  • Technical performance score is associated with outcomes after the Norwood procedure. 
  • Testing whether decision aids introduce cognitive biases: results of a randomized trial. 
  • Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. 
  • The Physician Recommendation Coding System (PhyReCS): A Reliable and Valid Method to Quantify the Strength of Physician Recommendations During Clinical Encounters. 
  • The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team. 
  • The Roles Of Assisters And Automated Decision Support Tools In Consumers' Marketplace Choices: Room For Improvement. 
  • The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders. 
  • The Value of Information in Decision-Analytic Modeling for Malaria Vector Control in East Africa 
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. 
  • The current clinical value of the DCIS Score. 
  • The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model. 
  • The economics of febrile neutropenia: implications for the use of colony-stimulating factors. 
  • The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma. 
  • The effect of changing disease risk on clinical reasoning. 
  • The effect of data sampling on the performance evaluation of artificial neural networks in medical diagnosis. 
  • The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument database. 
  • The experimental imperative. 
  • The final intraoperative parathyroid hormone level: how low should it go? 
  • The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings. 
  • The inclusion of patient testimonials in decision aids: effects on treatment choices. 
  • The management of fractures with soft-tissue disruptions. 
  • The management of fractures with soft-tissue disruptions. 
  • The rational clinical examination. Is this patient having a myocardial infarction? 
  • The role of decision analysis in informed consent: choosing between intuition and systematicity. 
  • The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations. 
  • The timing and influence of MRI on the management of patients with cervical facet dislocations remains highly variable: a survey of members of the Spine Trauma Study Group. 
  • The use of multiattribute decision models in evaluating triptan treatment options in migraine. 
  • The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. 
  • Theory-based approach to computer skill development in nursing administration. 
  • Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis. 
  • Thoroughly modern risk prediction? 
  • To what extent should quality of care decisions be based on health outcomes data? Application to carotid endarterectomy. 
  • Towards precision medicine: Accurate predictive modeling of infectious complications in combat casualties. 
  • Trends in Head Computed Tomography Utilization in Children Presenting to Emergency Departments After Traumatic Head Injury. 
  • U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis. 
  • Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement. 
  • Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. 
  • Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). 
  • Use of electrocardiogram indices of myocardial ischemia for risk stratification and decision making of reperfusion strategies. 
  • Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. 
  • Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. 
  • Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. 
  • Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. 
  • Using a wiki in nursing education and research. 
  • Using decision analysis to determine optimal experimental design for monitoring sewer exfiltration with tracers. 
  • Using decision analysis to improve malaria control policy making. 
  • Using evidence-based algorithms to improve clinical decision making: the case of a first-time anterior shoulder dislocation. 
  • Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study. 
  • Using outcomes data to identify best medical practice: the role of policy models. 
  • Using prospect theory to understand end-of-life decisions. 
  • Using surgical appropriateness criteria to examine outcomes of total knee arthroplasty in a United States sample. 
  • Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. 
  • Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalization. 
  • Utilizing Precision Medicine to Estimate Timing for Surgical Closure of Traumatic Extremity Wounds. 
  • Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. 
  • Validated prediction model for severe groin wound infection after lower extremity revascularization procedures. 
  • Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. 
  • Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): An analysis from the congenital cardiac interventional study consortium. 
  • Validation of serum progesterone <35nmol/L as a predictor of miscarriage among women with threatened miscarriage. 
  • Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology. 
  • What can decision analysis do for invasive species management? 
  • What threshold for adjuvant therapy in older breast cancer patients? 
  • When and how to study the carotid arteries. 
  • When and whom to screen. 
  • When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis. 
  • When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. 
  • Which approach to anticoagulation management is best? Illustration of an interactive mathematical model to support informed decision making. 
  • Which prognostic factors for low back pain are generic predictors of outcome across a range of recovery domains? 
  • Withholding versus withdrawing life-sustaining treatment: patient factors and documentation associated with dialysis decisions. 
  • Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. 
  • [Performance measures for prediction models and markers: evaluation of predictions and classifications]. 
• 

  Keywords of People

  • Anderson, Ruth A., Professor Emerita in the School of Nursing, School of Nursing
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Gellad, Ziad F., Associate Professor of Medicine, Medicine, Gastroenterology
  • Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Halstater, Brian Hugh, Associate Professor of Family Medicine and Community Health, Family Medicine and Community Health, Family Medicine
  • Lee, Richard H., Assistant Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition
  • Lo, Joseph Yuan-Chieh, Professor in Radiology, Electrical and Computer Engineering
  • Orlando, Lori Ann, Professor of Medicine, Medicine, General Internal Medicine
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics
  • Wolpert, Robert L., Professor Emeritus of Statistical Science, Environmental Sciences and Policy
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society